Project Grant HT9425261E068
Award Date 4/1/26
Completion Date 3/31/29
Dollars Obligated $669K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Australia
Similar Awards
- Federal Grant Award Summary The University of Melbourne received a $1,121,554 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period April 1, 2026 through March 31, 2029. The award supports research focused on developing novel biological therapies to target a tumor-specific isoform of HER2 (human epidermal growth factor receptor 2) for the treatment of advanced breast cancer. This research represents a...
- Federal Project Grant Award Summary The University of Melbourne has been awarded $721,656 by the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective November 1, 2025, with a completion date of October 31, 2028. The award supports a three-year research project focused on minimally-invasive measurement of pressure dynamics in the brain following traumatic brain injury (TBI). This research initiative aligns with the DHA's commitment to...
- Federal Project Grant Award Summary The Walter and Eliza Hall Institute of Medical Research (WEHI) received a $577,434 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period July 1, 2025 through June 30, 2028. The award supports research investigating a novel target to induce Major Histocompatibility Complex Class I (MHC-I) expression in lung adenocarcinoma. This research aligns with the program's focus on...
- Federal Grant Award Summary The University of Queensland received a $563,707 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective September 1, 2025, through August 31, 2028. The award supports research to develop predictive multiomics profiling methodologies for identifying early-stage melanoma cases at elevated risk of recurrence. This research directly aligns with the DHA's mission to advance biomedical solutions...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded The University of Queensland (UQ) a Project Grant totaling $506,785 under the Military Medical Research and Development program (CFDA 12.420) for the period September 1, 2025, through August 31, 2028. The research project, titled "Predicting Early-Stage Melanoma at High Risk of Recurrence Through Multiomics Profiling," focuses on developing advanced diagnostic methodologies to identify melanoma patients at elevated...
- Federal Project Grant Award Summary The University of Sydney received a $632,080 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period July 1, 2025 through June 30, 2028. The award supports research investigating survival factors among women with melanoma, a critical area of focus within the DHA's broader mission to advance biomedical research addressing health challenges relevant to military personnel...
- The Defense Health Agency awarded a $4,319,388 Project Grant to the University of Melbourne to fund research aimed at "TARGETING SENESCENT CELLS TO IMPROVE OUTCOMES FOR BREAST CANCER PATIENTS" over the period from September 1, 2024 to August 31, 2028. This grant is provided under the Military Medical Research and Development Program (CFDA 12.420), which supports biomedical research to improve the health and care of military service members, veterans, and their families. The...
- The federal Project Grant award, with ID HT94252410992, was provided by the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) federal grant program. The award, totaling $2,710,479.00, will fund a research initiative led by the University of Texas M.D. Anderson Cancer Center to advance the understanding of metastatic breast cancer through the development of a comprehensive research platform. The award's performance period is from August 15, 2024 to...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded The Trustees of Columbia University in the City of New York's Health Sciences Division a $1.645 million Project Grant under the Military Medical Research and Development program (CFDA 12.420) effective July 1, 2025, through June 30, 2028. The award supports research on treating HER2 therapy-resistant brain metastasis using antidepressants, conducted at Columbia's Health Sciences Division facility in New York, NY. This project...
- Federal Grant Award Summary The University of Queensland has been awarded $1,156,726 by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct a three-year research project spanning September 1, 2025, through August 31, 2028. The project, titled "Predicting Early-Stage Melanoma at High Risk of Recurrence Through Multiomics Profiling," focuses on developing innovative diagnostic capabilities to identify melanoma patients at...